SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-246134
Filing Date
2024-10-29
Accepted
2024-10-29 06:17:01
Documents
17
Period of Report
2024-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d902975d8k.htm   iXBRL 8-K 35657
2 EX-4.1 d902975dex41.htm EX-4.1 74035
3 EX-4.2 d902975dex42.htm EX-4.2 65467
4 EX-10.1 d902975dex101.htm EX-10.1 313598
5 EX-99.1 d902975dex991.htm EX-99.1 8270
  Complete submission text file 0001193125-24-246134.txt   756775

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA maia-20241028.xsd EX-101.SCH 2851
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20241028_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20241028_pre.xml EX-101.PRE 11708
19 EXTRACTED XBRL INSTANCE DOCUMENT d902975d8k_htm.xml XML 3744
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 241402526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)